نتایج جستجو برای: abcg2 gene

تعداد نتایج: 1142498  

Journal: :Investigative ophthalmology & visual science 2010
Miyuki Kubota Shigeto Shimmura Hideyuki Miyashita Motoko Kawashima Tetsuya Kawakita Kazuo Tsubota

PURPOSE ABCG2 is a putative marker of progenitor cells, including the corneal epithelium. The authors investigated whether ABCG2 functions in the homeostasis of corneal epithelial cells using abcg2 knockout (KO) mice and corneal epithelial cell lines. METHODS abcg2 KO mice and a spontaneously immortalized murine corneal epithelial cell line (TKE2) were used for experiments. Flow cytometry was...

Journal: :Biochemistry 2005
Ndeye K Diop Christine A Hrycyna

The human ATP-binding cassette half-transporter ABCG2 is a 72 kDa plasma membrane protein that can confer multidrug resistance to cells in culture when overexpressed. Both transiently and stably expressed ABCG2 are glycosylated, and treatment with peptide N-glycosidase F reduces the apparent molecular mass on SDS-PAGE gels to approximately 60 kDa. Sequence analysis revealed three potential N-li...

Journal: :Molecular pharmacology 2009
Yu-Zhuo Pan Marilyn E Morris Ai-Ming Yu

Breast cancer resistance protein (BCRP/ABCG2) is a molecular determinant of pharmacokinetic properties of many drugs in humans. To understand post-transcriptional regulation of ABCG2 and the role of microRNAs (miRNAs) in drug disposition, we found that microRNA-328 (miR-328) might readily target the 3'-untranslated region (3'-UTR) of ABCG2 when considering target-site accessibility. We then not...

Journal: :The Journal of pharmacology and experimental therapeutics 2006
Hikaru Saito Hiroyuki Hirano Hiroshi Nakagawa Takeaki Fukami Keisuke Oosumi Kaori Murakami Hiroko Kimura Takayuki Kouchi Mami Konomi Eriko Tao Noboru Tsujikawa Shigeki Tarui Makoto Nagakura Masako Osumi Toshihisa Ishikawa

The human ATP-binding cassette (ABC) transporter ABCG2 (BCRP/MXR1/ABCP) plays a critical role in cellular protection against xenobiotics as well as pharmacokinetics of drugs in our body. In the present study, we aimed to analyze the quantitative structure-activity relationship (QSAR) latently residing in ABCG2-drug interactions. We first established standard methods for expression of human ABCG...

Journal: :Molecular cancer therapeutics 2009
Kenneth K W To Robert W Robey Turid Knutsen Zhirong Zhan Thomas Ried Susan E Bates

Overexpression of ABCG2 has been reported in cell lines selected for drug resistance and it is widely believed to be important in the clinical pharmacology of anticancer drugs. We and others have previously identified and validated two microRNAs (miRNA; hsa-miR-519c and hsa-miR-520h) targeting ABCG2. In this study, the shortening of the ABCG2 3' untranslated region (3'UTR) was found to be a com...

2011

The second-generation tyrosine kinase inhibitor and anticancer drug axitinib is a potent, orally active inhibitor of the vascular endothelial growth factor receptors 1, 2, and 3. Axitinib has clinical activity against solid tumors such as metastatic renal cell carcinoma and advanced pancreatic cancer. We studied axitinib transport using Madin-Darby canine kidney II cells overexpressing human AB...

2017
Toshihide Higashino Tappei Takada Hirofumi Nakaoka Yu Toyoda Blanka Stiburkova Hiroshi Miyata Yuki Ikebuchi Hiroshi Nakashima Seiko Shimizu Makoto Kawaguchi Masayuki Sakiyama Akiyoshi Nakayama Airi Akashi Yuki Tanahashi Yusuke Kawamura Takahiro Nakamura Kenji Wakai Rieko Okada Ken Yamamoto Kazuyoshi Hosomichi Tatsuo Hosoya Kimiyoshi Ichida Hiroshi Ooyama Hiroshi Suzuki Ituro Inoue Tony R Merriman Nariyoshi Shinomiya Hirotaka Matsuo

Objective Previous studies have suggested an association between gout susceptibility and common dysfunctional variants in ATP-binding cassette transporter subfamily G member 2/breast cancer resistance protein (ABCG2/BCRP), including rs72552713 (Q126X) and rs2231142 (Q141K). However, the association of rare ABCG2 variants with gout is unknown. Therefore, we investigated the effects of rare ABCG2...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2011
Birk Poller Dilek Iusuf Rolf W Sparidans Els Wagenaar Jos H Beijnen Alfred H Schinkel

The second-generation tyrosine kinase inhibitor and anticancer drug axitinib is a potent, orally active inhibitor of the vascular endothelial growth factor receptors 1, 2, and 3. Axitinib has clinical activity against solid tumors such as metastatic renal cell carcinoma and advanced pancreatic cancer. We studied axitinib transport using Madin-Darby canine kidney II cells overexpressing human AB...

2016
Hirotaka Matsuo Tomoyuki Tsunoda Keiko Ooyama Masayuki Sakiyama Tsuyoshi Sogo Tappei Takada Akio Nakashima Akiyoshi Nakayama Makoto Kawaguchi Toshihide Higashino Kenji Wakai Hiroshi Ooyama Ryota Hokari Hiroshi Suzuki Kimiyoshi Ichida Ayano Inui Shin Fujimori Nariyoshi Shinomiya

To clarify the physiological and pathophysiological roles of intestinal urate excretion via ABCG2 in humans, we genotyped ABCG2 dysfunctional common variants, Q126X (rs72552713) and Q141K (rs2231142), in end-stage renal disease (hemodialysis) and acute gastroenteritis patients, respectively. ABCG2 dysfunction markedly increased serum uric acid (SUA) levels in 106 hemodialysis patients (P = 1.1 ...

2011
Michelle J. Doyle Sheng Zhou Kathleen Kelly Tanaka Addolorata Pisconti Nicholas H. Farina Brian P. Sorrentino Bradley B. Olwin

Skeletal muscle contains progenitor cells (satellite cells) that maintain and repair muscle. It also contains muscle side population (SP) cells, which express Abcg2 and may participate in muscle regeneration or may represent a source of satellite cell replenishment. In Abcg2-null mice, the SP fraction is lost in skeletal muscle, although the significance of this loss was previously unknown. We ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید